The investment seeks long-term capital appreciation with a secondary emphasis on capital preservation. The fund is considered a "fund of funds" that seeks to achieve its investment objective by primarily investing in other exchange-traded funds that offer diversified exposure to global regions, countries, styles (market capitalization, value, growth, etc.) or sectors, and other exchange-traded products. It primarily invests in U.S.-listed domestic and foreign equity, fixed income, and commodity ETPs. The Sub-Advisor uses a quantitative tactical methodology to identify the ETPs believed to be participating in long-term "durable trends" within the market.
Inception Date: 22/06/2011
Primary Benchmark: S&P 500 TR USD
Primary Index: Morningstar Mod Tgt Risk TR USD
Gross Expense Ratio: 1.88%
Management Expense Ratio: 1.35 %
|IJR||iShares Core S&P Small-Cap||28.38 %|
|IJH||iShares Core S&P Mid-Cap||18.92 %|
|EEM||iShares MSCI Emerging Index Fund||10.09 %|
|IBB||iShares Nasdaq Biotechnology Index Fund||9.81 %|
|KRE||SPDR S&P Regional Banking||9.72 %|
|XLF||SPDR Select Sector Fund - Financial||9.71 %|
|IYH||iShares U.S. Healthcare||9.63 %|
|NHF||NexPoint Credit Strategies Fun..||0.00 %||
|OPP||RiverNorth/DoubleLine Strategi..||0.00 %||
|FT||Franklin Universal Trust||0.00 %||
|DNI||Dividend and Income Fund||0.00 %||
|SPE||Special Opportunities Fund Inc||0.00 %||
|RIV||RiverNorth Opportunities Fund ..||0.00 %||
|YYY||YieldShares High Income||0.50 %||
|CPI||IQ Real Return||0.49 %||
|GTAA||AdvisorShares Morgan Creek Glo..||1.25 %||
|Market Performance vs.
Industry/Classification (Tactical Allocation)
|Market Performance vs. Exchange (NYSE Arca)|
|Value||Sector Median||Percentile Rank||Grade||Market Median||Percentile Rank||Grade|
|Trailing 12 Months|
|Trailing 5 Years|
|Average Annual (5 Year Horizon)|
|Risk Return Profile|
|Volatility (Standard Deviation)||9.11%||70%||C-||74%||C|
|Risk Adjusted Return||31.85%||30%||F||34%||F|
|Target Price Action||Rating Action||Analyst||Rating||Price||Date|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
There is nothing we particularly like
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
The company has under performed its peers on annual average total returns in the past 5 years.
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.